BIOINFORMATICS PLATFORMS MARKET ANALYSIS
For instance, in October 2013, Qiagen acquired CLC Bio, a Denmark-based bioinformatics software company. CLC Bio was focused on developing and marketing software for analyzing genomic data from next-generation sequencing platforms and conventional Sanger sequencing instruments. The acquisition integrated CLC Bio’s product portfolio including CLC Genomics Workbench, CLC Main Workbench, and CLC Genomics Server to Qiagen’s portfolio.
Increasing development of high-throughput bioinformatics platform leads to a constant boost in the volume of data available for analysis, resulting in data deluge. Such large amount of data leads to an increasing need for analysis, annotation, retrieval, and storage. Moreover, consideration of storage and processing, as well as the transfer of data between collaborating partners, are often involves integration of advanced software and hardware support.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 